Gene: ETFDH
Official Full Name: electron transfer flavoprotein dehydrogenaseprovided by HGNC
Gene Summary: This gene encodes a component of the electron-transfer system in mitochondria and is essential for electron transfer from a number of mitochondrial flavin-containing dehydrogenases to the main respiratory chain. Mutations in this gene are associated with glutaric acidemia. Alternatively spliced transcript variants that encode distinct isoforms have been observed. [provided by RefSeq, Aug 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37955 | ETFDH Knockout cell line (HeLa) | Human | ETFDH | 1:3~1:6 | Negative | Online Inquiry |
KO37956 | ETFDH Knockout cell line (HCT 116) | Human | ETFDH | 1:2~1:4 | Negative | Online Inquiry |
KO37957 | ETFDH Knockout cell line (HEK293) | Human | ETFDH | 1:3~1:6 | Negative | Online Inquiry |
KO37958 | ETFDH Knockout cell line (A549) | Human | ETFDH | 1:3~1:4 | Negative | Online Inquiry |
ETFDH Gene Knockout Cell Lines are specially engineered cell lines that facilitate targeted investigations into the biological functions of the ETFDH gene, which encodes for a mitochondrial enzyme critical in fatty acid and amino acid metabolism. By employing CRISPR/Cas9 gene-editing technology, these cell lines are designed to produce knockout variants that lack functional ETFDH. This targeted approach allows researchers to elucidate the role of ETFDH in metabolic pathways, cellular energy production, and mitochondrial dysfunction, critical areas of study in metabolic disorders, neurodegeneration, and cancer.
The mechanism of action involves the selective disruption of the ETFDH gene, providing researchers with a powerful model to study the consequences of its absence on cellular physiology. By comparing the knockout cell lines with wild-type counterparts, researchers can observe changes in metabolic flux, mitochondrial respiration, and oxidative stress responses. This information is invaluable in the quest to understand various pathologies associated with ETFDH deficiency, such as myopathy or encephalopathy.
Scientifically, these cell lines open up new avenues for drug discovery and therapeutic interventions, allowing for high-throughput screening of compounds that could potentially restore normal function or mitigate the consequences of ETFDH loss. Compared to conventional models, ETFDH Gene Knockout Cell Lines offer unparalleled specificity and relevance to human diseases, making them an essential resource for researchers focused on mitochondrial biology and associated disorders.
Users will find value in these cell lines due to their potential to yield insightful data critical for advancing our understanding of ETFDH-related conditions. Researchers and clinicians can rely on the robustness and reliability of these models in experimental setups, thereby accelerating the path toward novel treatments.
Our company specializes in providing quality biological products for cutting-edge research, with a commitment to advancing scientific knowledge in molecular biology and genetics. With our ETFDH Gene Knockout Cell Lines, you gain access to precisely engineered tools that enhance your research capabilities and drive innovation in your studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.